Concepedia

M.C. Bibby

MB

Statistics

Publications

21

Citations

761

H-Index

17

Active since

1971

Affiliations

University of Bradford(Current)

University of Manchester

Aberystwyth University

M.C. Bibby is an author at University of Bradford specializing in pharmacology, medicine, and oncology.

Publications per year

1971–2003

21

Publications

21

Preliminary experimental anticancer activity of cecropins.

Alison Moore, Donna Devine, M.C. Bibby · PubMed · 1995 · 165 citations

, , +12

EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models

Hans R. Hendriks, P. E. Pizao, Dan Berger et al. · European Journal of Cancer · 1993 · 104 citations · Full text

, , +7

Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1.

Paul M. Loadman, M.C. Bibby, John A. Double et al. · PubMed · 1999 · 51 citations

, , +14

Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate.

S E Holwell, Patricia A. Cooper, Michael J. Thompson et al. · PubMed · 2003 · 46 citations

, , +12

Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311

AM Burger, T.C. Jenkins, J A Double et al. · British Journal of Cancer · 1999 · 39 citations · Full text

, , +16

1–5 of 21